News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Child developmental issues news

Show

From To
HIV treatment for children and young people
Anti-HIV therapy appears to protect children's hearts, NIH network study shows

For children who have had HIV-1 infection since birth, the combination drug therapies now used to treat HIV appear to protect against the heart damage seen before combination therapies were available, according to researchers.

Published
23 April 2013
From
National Institutes of Health (press release)
Child developmental issues
HIV Drug Not Tied to Premature Births

Pregnant HIV-infected women treated with a lopinavir/ritonavir (Kaletra)-based antiretroviral regimen are at no greater risk of delivering a preterm baby than similar pregnant women given an efavirenz (Sustiva)-based treatment, researchers said here.

Published
10 March 2013
From
MedPage Today
Nutrition
Texas: Food availability linked with poor outcomes for HIV-positive children

An HIV-positive child whose family does not have enough good food available is more likely to have a poor clinical outcome, researchers reported. They found that children who did not always have enough to eat had lower CD4 counts as well as higher chances of incomplete viral suppression.

Published
12 February 2013
From
Baylor College of Medicine press release
Child developmental issues
Bone mineral density below normal in children infected early with HIV

Bone mineral density was below the general population norm in US children perinatally infected with HIV and lower than in children perinatally exposed to HIV but uninfected.

Published
21 January 2013
From
International AIDS Society
Child developmental issues
Atherosclerosis Found in HIV Children

Children with HIV have a 2.5 fold increased risk of atherosclerosis, according to research presented at EUROECHO and other Imaging Modalities 2012.

Published
06 December 2012
From
Science Daily (press release)
Prevention of mother-to-child transmission
Adverse birth outcomes more frequent in women exposed to ART during pregnancy, largest-ever study confirms

Among HIV-infected women in Botswana, starting combination antiretroviral therapy during pregnancy was associated with an increased risk for adverse birth outcomes, including pre-term delivery, small for gestational age,

Published
30 October 2012
By
Carole Leach-Lemens
Child developmental issues
Children exposed to HIV in the womb at increased risk for hearing loss

Children exposed to HIV in the womb may be more likely to experience hearing loss by age 16 than are their unexposed peers, according to scientists in a National Institutes of Health research network.

Published
21 June 2012
From
Eurekalert Medicine & Health
Prevention of mother-to-child transmission
Anti-HIV drug use during pregnancy does not affect infant size, birth weight

Infants born to women who used the anti-HIV drug tenofovir as part of an anti-HIV drug regimen during pregnancy do not weigh less at birth and are not of shorter length than infants born to women who used anti-HIV drug regimens that do not include tenofovir during pregnancy, according to findings from a National Institutes of Health network study.

Published
02 May 2012
From
National Institutes of Health (press release)
Child developmental issues
Tenofovir use during pregnancy doesn't affect infant size or weight at birth, but may by one year of age

Use of tenofovir during pregnancy does not have an adverse impact on infant weight or size at birth, according to a large US study published in the

Published
03 April 2012
By
Michael Carter
Child developmental issues
Time HIV Tx Starts Has No Impact on IQ

Neurological development of children infected with HIV does not appear to be influenced by the decision on when to start antiretroviral therapy, researchers said here.

Published
08 March 2012
From
MedPage Today
← Prev1...45678Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.